X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (634) 634
Publication (45) 45
Book Review (12) 12
Book Chapter (5) 5
Conference Proceeding (2) 2
Data Set (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
t-plasminogen activator (640) 640
index medicus (384) 384
stroke (304) 304
ischemia (282) 282
humans (263) 263
tissue plasminogen activator (263) 263
thrombolysis (247) 247
male (203) 203
hemorrhage (182) 182
female (167) 167
patients (163) 163
intravenous administration (142) 142
medicine (141) 141
multidisciplinary sciences (136) 136
animals (131) 131
science (125) 125
aged (120) 120
research article (116) 116
middle aged (114) 114
fibrin (110) 110
mortality (110) 110
proteins (109) 109
recombinant (104) 104
fibrinolysis (95) 95
thrombosis (95) 95
tissue-plasminogen activator (93) 93
analysis (91) 91
neurosciences (91) 91
tissue plasminogen activator - therapeutic use (91) 91
brain (86) 86
studies (86) 86
stroke - drug therapy (81) 81
therapy (80) 80
plasminogen activator inhibitors (79) 79
clinical neurology (77) 77
acute ischemic-stroke (76) 76
inflammation (76) 76
mice (76) 76
neurology (76) 76
risk factors (76) 76
care and treatment (75) 75
reperfusion (72) 72
clinical trials (70) 70
treatment outcome (70) 70
rodents (67) 67
research (65) 65
aged, 80 and over (63) 63
medical research (63) 63
cerebral blood flow (61) 61
fibrinolytic agents - therapeutic use (61) 61
blood (59) 59
health aspects (58) 58
tissue plasminogen activator - administration & dosage (58) 58
hospitals (57) 57
ischemic stroke (57) 57
plasmin (57) 57
adult (56) 56
occlusion (56) 56
surgery (56) 56
u-plasminogen activator (56) 56
cell biology (54) 54
gene expression (54) 54
physiology (53) 53
medical imaging (52) 52
heart attacks (51) 51
medicine and health sciences (51) 51
blood coagulation (50) 50
animal models (49) 49
bleeding (49) 49
catheters (49) 49
enzymes (49) 49
myocardial infarction (49) 49
thrombolytic therapy (49) 49
biology (48) 48
transformation (48) 48
biology and life sciences (47) 47
blood-brain barrier (47) 47
brain ischemia - drug therapy (47) 47
cerebral infarction (47) 47
rats (47) 47
thromboembolism (47) 47
neuroprotection (46) 46
plasminogen (46) 46
tissue plasminogen activator - metabolism (46) 46
cardiovascular disease (45) 45
blood clots (44) 44
veins & arteries (44) 44
article (43) 43
neuroimaging (43) 43
physiological aspects (43) 43
tpa (43) 43
biochemistry (42) 42
cardiovascular diseases (42) 42
hematology (42) 42
infarction (42) 42
thrombolytic therapy - methods (42) 42
management (41) 41
alteplase (40) 40
immunology (40) 40
expression (39) 39
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Brain, ISSN 0006-8950, 2012, Volume 135, Issue 11, pp. 3251 - 3264
The neurovascular unit provides a dynamic interface between the circulation and central nervous system. Disruption of neurovascular integrity occurs in... 
traumatic brain injury | matrix metalloproteinase-3 | plasminogen activator inhibitor-1 | tissue plasminogen activator | neurovascular unit | MULTIPLE-SCLEROSIS LESIONS | RECEPTOR-RELATED PROTEIN | TPA | FOCAL CEREBRAL-ISCHEMIA | BARRIER BREAKDOWN | NEUROSCIENCES | CLINICAL NEUROLOGY | STROKE | MATRIX METALLOPROTEINASES | CENTRAL-NERVOUS-SYSTEM | EXPRESSION | BLOOD | Capillary Permeability - physiology | Tissue Plasminogen Activator - metabolism | Brain Injuries - drug therapy | Humans | Middle Aged | Injections, Intraventricular | Capillary Permeability - drug effects | Male | Brain Injuries - metabolism | Brain Injuries - physiopathology | Plasminogen Activator Inhibitor 1 - physiology | Matrix Metalloproteinase Inhibitors - therapeutic use | Brain - metabolism | Dose-Response Relationship, Drug | Brain - blood supply | Tissue Plasminogen Activator - antagonists & inhibitors | Plasminogen Activator Inhibitor 1 - metabolism | Aged, 80 and over | Recovery of Function - physiology | Adult | Disease Models, Animal | Albumins - metabolism | Mice, Inbred C57BL | Plasminogen Activator Inhibitor 1 - administration & dosage | Tissue Plasminogen Activator - administration & dosage | Tissue Plasminogen Activator - physiology | Animals | Brain Injuries - cerebrospinal fluid | Aged | Mice | Matrix Metalloproteinases - metabolism | Stroke | Central nervous system | Membrane permeability | Albumin | Homeostasis | Cerebrospinal fluid | Matrix metalloproteinase | Permeability | Trauma | Plasmin | t-Plasminogen activator | lipoprotein receptors | neuroserpin | plasminogen | Proteolysis | Plasma membranes | Chromium | Serine proteinase | Brain injury | Original
Journal Article
European Journal of Neuroscience, ISSN 0953-816X, 03/2017, Volume 45, Issue 6, pp. 805 - 815
Glutamate phase shifts the circadian clock in the mammalian suprachiasmatic nucleus ( SCN ) by activating NMDA receptors. Tissue‐type plasminogen activator (... 
urokinase‐type plasminogen activator | circadian rhythms | suprachiasmatic nucleus | tissue‐type plasminogen activator | urokinase-type plasminogen activator | tissue-type plasminogen activator | NEURONAL MIGRATION | CELL-ADHESION MOLECULE | NEUROTROPHIC FACTOR | RECEPTOR | NEUROSCIENCES | IN-VITRO | EXTRACELLULAR-MATRIX | BIOLOGICAL CLOCK | BRAIN | GENE-FUNCTION | Brain-Derived Neurotrophic Factor - genetics | Suprachiasmatic Nucleus - drug effects | Tissue Plasminogen Activator - metabolism | Mice, Inbred C57BL | Plasminogen Inactivators - pharmacology | Male | Tissue Plasminogen Activator - genetics | Suprachiasmatic Nucleus - physiology | Animals | Urokinase-Type Plasminogen Activator - metabolism | Proteolysis | Circadian Clocks | Female | Suprachiasmatic Nucleus - metabolism | Brain-Derived Neurotrophic Factor - metabolism | Mice | Urokinase | Glutamate | Tissue plasminogen activator | Laws, regulations and rules | Suprachiasmatic nucleus | Glutamic acid | Brain | Night | Glutamic acid receptors (ionotropic) | Brain slice preparation | Nuclei | Plasmin | t-Plasminogen activator | Receptors | Casein | Rodents | Entrainment | Inhibition | Biological clocks | Circadian rhythms | Phase transformations | Phase shift | Polyamide-imides | N-Methyl-D-aspartic acid receptors | Circadian rhythm | Mammals | U-Plasminogen activator | Brain-derived neurotrophic factor | Inhibitors | Plasminogen activator inhibitors | TrkB receptors | Glutamatergic transmission | Gates
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2011, Volume 365, Issue 6, pp. 518 - 526
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 11/2017, Volume 174, Issue 21, pp. 3823 - 3836
Journal Article
Journal of Veterinary Internal Medicine, ISSN 0891-6640, 09/2015, Volume 29, Issue 5, pp. 1403 - 1409
Journal Article